|
DE19537012A1
(de)
*
|
1995-10-04 |
1997-04-10 |
Dietl Hans |
Cyclosporin(e) enhaltende pharmazeutische Zubereitung zur oralen Applikation und Verfahren zu ihrer Herstellung
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
|
US6054421A
(en)
*
|
1997-09-23 |
2000-04-25 |
Scimed Life Systems, Inc. |
Medical emulsion lubricant
|
|
DE19810655A1
(de)
*
|
1998-03-12 |
1999-09-16 |
Univ Eberhard Karls |
Arzneimittel mit einem Gehalt an Ciclosporin
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
AU764001B2
(en)
|
1998-05-29 |
2003-08-07 |
Skyepharma Canada Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
|
US7030155B2
(en)
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
CN1221249C
(zh)
|
1998-08-19 |
2005-10-05 |
斯凯伊药品加拿大公司 |
普鲁泊福的可注射水分散体
|
|
SK288117B6
(sk)
|
1998-11-20 |
2013-09-03 |
Skyepharma Canada Inc. |
Rapidly dispersing solid dry therapeutic dosage form
|
|
IL143604A0
(en)
|
1998-12-30 |
2002-04-21 |
Dexcel Ltd |
Dispersable concentrate for the delivery of cyclosporin
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
WO2001028519A1
(de)
*
|
1999-10-20 |
2001-04-26 |
Vesifact Ag |
Mikroemulsion-prekonzentrate und mikroemulsionen
|
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
|
DE19961733A1
(de)
*
|
1999-12-21 |
2001-06-28 |
Ciclomulsion Ag |
Cyclosporin(e) enthaltende hypertone pharmazeutische Zubereitung zur Anwendung bei neurologischen Erkrankungen und als Neuroprotektivum sowie Verfahren zu ihrer Herstellung
|
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
|
DE10030378A1
(de)
*
|
2000-06-21 |
2002-03-14 |
Audit Inst For Medical Service |
Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen
|
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
|
US6607784B2
(en)
*
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
MXPA04002446A
(es)
|
2001-09-26 |
2004-07-23 |
Baxter Int |
Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
EP1435910B9
(en)
*
|
2001-10-19 |
2010-02-03 |
Isotechnika Inc. |
Novel cyclosporin analog microemulsion preconcentrates
|
|
RU2301679C2
(ru)
*
|
2001-12-14 |
2007-06-27 |
Яготек Аг |
Фармацевтический препарат, содержащий циклоспорин, и его применение
|
|
MXPA04005783A
(es)
*
|
2001-12-14 |
2004-09-13 |
Jagotec Ag |
Formulacion farmaceutica que comprende ciclosporina y uso de la misma.
|
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
JP2007520555A
(ja)
*
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
自己安定化剤の使用により調製された分散剤
|
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
DE102006051512A1
(de)
*
|
2005-12-06 |
2007-06-14 |
Pari GmbH Spezialisten für effektive Inhalation |
Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
|
|
US10137083B2
(en)
*
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
|
US11311477B2
(en)
*
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
|
EP2020990B1
(en)
|
2006-05-30 |
2010-09-22 |
Intarcia Therapeutics, Inc |
Two-piece, internal-channel osmotic delivery system flow modulator
|
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
|
CN101848702B
(zh)
|
2006-12-01 |
2013-07-17 |
安特里奥公司 |
两亲实体纳米粒子
|
|
SG10201607909WA
(en)
*
|
2006-12-01 |
2016-11-29 |
Anterios Inc |
Peptide nanoparticles and uses therefor
|
|
US10265265B2
(en)
*
|
2007-03-15 |
2019-04-23 |
Drug Delivery Solutions Limited |
Topical composition
|
|
US20080234232A1
(en)
*
|
2007-03-20 |
2008-09-25 |
Flynn Daniel C |
Methods and compositions for targeting AFAP
|
|
JP5135852B2
(ja)
|
2007-03-30 |
2013-02-06 |
日油株式会社 |
可溶化用組成物
|
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
AR066901A1
(es)
*
|
2007-05-18 |
2009-09-23 |
Alcon Mfg Ltd |
Composiciones fodfolipidicas para elcuidado de lentes de contacto y conservacion de composiciones farmaceuticas
|
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
WO2008151022A2
(en)
|
2007-05-31 |
2008-12-11 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
|
EP2008651A1
(en)
|
2007-06-26 |
2008-12-31 |
Drug Delivery Solutions Limited |
A bioerodible patch
|
|
MX340897B
(es)
|
2007-10-02 |
2016-07-29 |
Theranos Inc |
Dispositivos modulares de punto de cuidado y usos de los mismos.
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
TW201010727A
(en)
*
|
2008-09-03 |
2010-03-16 |
Alcon Res Ltd |
Pharmaceutical composition having relatively low ionic strength
|
|
JP2012514645A
(ja)
*
|
2009-01-08 |
2012-06-28 |
アラーガン インコーポレイテッド |
爪成長の増進用組成物
|
|
EP3323423B1
(en)
|
2009-09-28 |
2020-06-17 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
CN102639129B
(zh)
|
2009-11-17 |
2016-08-24 |
迈克尔·A·福兰 |
含游离脂肪酸的抗微生物组合物
|
|
JP2012051823A
(ja)
*
|
2010-08-31 |
2012-03-15 |
Fujifilm Corp |
難容性薬物含有水中油型乳化組成物及びその製造方法
|
|
WO2012069149A1
(en)
*
|
2010-11-23 |
2012-05-31 |
Merck Patent Gmbh |
Solution comprising cyclic oligopeptides
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
US9610245B2
(en)
|
2011-03-14 |
2017-04-04 |
Drug Delivery Solutions Limited |
Ophthalmic composition
|
|
KR101492447B1
(ko)
|
2013-05-20 |
2015-02-23 |
주식회사태준제약 |
사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
ES2968262T3
(es)
|
2015-06-03 |
2024-05-08 |
I2O Therapeutics Inc |
Sistemas de colocación de implantes
|
|
KR20240037175A
(ko)
|
2016-05-16 |
2024-03-21 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
EP3541358A1
(en)
|
2016-11-21 |
2019-09-25 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
|
AU2018206539A1
(en)
|
2017-01-03 |
2019-07-18 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
|
EP3542788A1
(en)
|
2018-03-19 |
2019-09-25 |
MC2 Therapeutics Limited |
Topical composition comprising calcipotriol and betamethasone dipropionate
|
|
WO2020056191A1
(en)
|
2018-09-13 |
2020-03-19 |
Eirion Therapeutics, Inc. |
Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
|